All 20 LFSC (F/M EMERALD LIFE SCIENCES INNOVATION ETF) Holdings
There are 20 LFSC holdings. Top 10 companies weight: 54.11%.
Total Market Cap: $118B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (20 stocks) | +2.94% | 25.28 | 12.06 | 0.37 | +31.80% | +17.04% | 1.02 | ||||||||||
1 | COGT | Cogent Biosciences Inc | 7.45% | $32.76 | $5.89B | Biotechnology | Healthcare | -15.32% | N/A | N/A | N/A | N/A | N/A | 75 | +65.60% | $54 | +32.60% | 1.74 |
2 | LIVN | Livanova Plc | 7.41% | $73.33 | $4.06B | Medical Devices | Healthcare | N/A | 37.71 | 17.45 | 0.84 | N/A | N/A | 72 | +9.91% | $81 | -1.54% | 0.92 |
3 | TVTX | Travere Therapeutics Inc Ordinary Shares | 7.34% | $42.96 | $4.41B | Biotechnology | Healthcare | -44.12% | N/A | 61.73 | N/A | N/A | N/A | 76 | +26.02% | $54 | +24.56% | 1.30 |
4 | SYRE | Spyre Therapeutics Inc | 6.55% | $69.16 | $5.72B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +37.65% | $95 | -16.21% | 1.74 |
5 | GH | Guardant Health Inc | 5.20% | $130.17 | $17B | Diagnostics & Research | Healthcare | +1.05% | N/A | N/A | N/A | N/A | N/A | 75 | +0.82% | $131 | +2.00% | 1.22 |
6 | MIRM | Mirum Pharmaceuticals Inc | 4.89% | $92.17 | $5.93B | Biotechnology | Healthcare | -34.51% | N/A | 2000.00 | N/A | N/A | N/A | 82 | +56.40% | $144 | +40.23% | 0.90 |
7 | UTHR | United Therapeutics Corp | 4.41% | $540.05 | $24B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 19.28 | 19.88 | 2.05 | N/A | N/A | 71 | +23.18% | $665 | +25.24% | 0.45 |
8 | CORT | Corcept Therapeutics Inc | 4.07% | $71.20 | $6.96B | Biotechnology | Healthcare | -8.23% | 158.39 | 85.47 | 0.81 | N/A | N/A | N/A | N/A | N/A | +26.78% | N/A |
9 | MANE | Veradermics Inc | 3.54% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
10 | SVRA | Savara Inc | 3.25% | $5.25 | $1.07B | Biotechnology | Healthcare | -2.12% | N/A | 0.41 | N/A | N/A | N/A | 81 | +105.90% | $11 | +23.87% | 1.21 |
11 | NKTR | Nektar Therapeutics | 3.24% | $58.56 | $1.62B | Biotechnology | Healthcare | -24.01% | N/A | 34.01 | 0.31 | N/A | N/A | 75 | +161.70% | $153 | -26.23% | 1.86 |
12 | TRVI | Trevi Therapeutics Inc | 3.23% | $13.50 | $1.86B | Biotechnology | Healthcare | -27.09% | N/A | N/A | N/A | N/A | N/A | 79 | +77.04% | $24 | +43.35% | 0.64 |
13 | CYTK | Cytokinetics Inc | 3.21% | $70.91 | $9.51B | Biotechnology | Healthcare | +27.73% | N/A | 117.65 | N/A | N/A | N/A | N/A | N/A | N/A | +27.51% | N/A |
14 | DNTH | Dianthus Therapeutics Inc | 2.94% | $81.57 | $4.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
15 | AXSM | Axsome Therapeutics Inc | 2.89% | $222.16 | $12B | Biotechnology | Healthcare | +6.89% | N/A | 333.33 | N/A | N/A | N/A | 77 | +21.66% | $270 | +29.20% | 0.68 |
16 | TMDX | Transmedics Group Inc | 2.87% | $68.45 | $2.42B | Medical Devices | Healthcare | N/A | 13.96 | 30.96 | 0.06 | N/A | N/A | 75 | +70.61% | $117 | +22.00% | 1.20 |
17 | BLLN | Billiontoone Inc Ordinary Shares Class A | 2.38% | $94.25 | $4.18B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +24.89% | $118 | 0.00% | 1.89 |
18 | VRDN | Viridian Therapeutics Inc | 2.20% | $15.87 | $1.77B | Biotechnology | Healthcare | -32.36% | N/A | 1.01 | N/A | N/A | N/A | 77 | +113.86% | $34 | -0.90% | 1.10 |
19 | ICUI | Icu Medical Inc | 2.13% | $130.48 | $3.46B | Medical Instruments & Supplies | Healthcare | -16.01% | 74.28 | 16.13 | 0.08 | N/A | N/A | 82 | +32.48% | $173 | -8.64% | 1.16 |
20 | CRVS | Corvus Pharmaceuticals Inc | 2.06% | $11.69 | $1.09B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | +34.16% | N/A |
LFSC (F/M EMERALD LIFE SCIENCES INNOVATION ETF) Sector Allocation
HEALTHCARE
97.80%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%